Par Pharmaceutical Brevital recalls
The FDA has published 1 recall involving Par Pharmaceutical Brevital since 2026. The latest was reported on 9 Oct 2026. Most were for particulate matter. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2026
Last 12 months1reported
Class I00% of total
Ongoing1latest 9 Oct 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 0 0%Other/pending 1
Why par pharmaceutical brevital is recalled
Companies
By year
Ongoing par pharmaceutical brevital recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | ANNOUNCED | Par Pharmaceutical Brevital Sodium 500 mg/vial for Injection recalledPar Pharmaceutical | Par Health | Particulate Matter | Nationwide |
All par pharmaceutical brevital recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | ANNOUNCED | Par Pharmaceutical Brevital Sodium 500 mg/vial for Injection recalledPar Pharmaceutical | Par Health | Particulate Matter | Nationwide |
Should you stop taking Par Pharmaceutical Brevital?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.